Nogales E, Downing KH, Amos LA, Löwe J (June 1998). "Tubulin and FtsZ form a distinct family of GTPases". Nature Structural Biology. 5 (6): 451–8. doi:10.1038/nsb0698-451. PMID9628483. S2CID5945125.
Williams RC, Shah C, Sackett D (November 1999). "Separation of tubulin isoforms by isoelectric focusing in immobilized pH gradient gels". Analytical Biochemistry. 275 (2): 265–7. doi:10.1006/abio.1999.4326. PMID10552916.
Karki R, Mariani M, Andreoli M, He S, Scambia G, Shahabi S, Ferlini C (April 2013). "βIII-Tubulin: biomarker of taxane resistance or drug target?". Expert Opinion on Therapeutic Targets. 17 (4): 461–72. doi:10.1517/14728222.2013.766170. PMID23379899. S2CID26229777.
Malone, Lucia M.; Warring, Suzanne L.; Jackson, Simon A.; Warnecke, Carolin; Gardner, Paul P.; Gumy, Laura F.; Fineran, Peter C. (9 December 2019). "A jumbo phage that forms a nucleus-like structure evades CRISPR–Cas DNA targeting but is vulnerable to type III RNA-based immunity". Nature Microbiology. 5 (1): 48–55. bioRxiv10.1101/782524. doi:10.1038/s41564-019-0612-5. PMID31819217. S2CID209164667.
Akıl, Caner; Ali, Samson; Tran, Linh T.; Gaillard, Jeremie; Li, Wenfei; Hayashida, Kenichi; Hirose, Mika; Kato, Takayuki; Oshima, Atsunori; Fujishima, Kosuke; Blanchoin, Laurent; Narita, Akihiro; Robinson, Robert C. (2021). "Structure and dynamics of Odinarchaeota tubulin and the implications for eukaryotic microtubule evolution". bioRxiv10.1101/2021.10.22.465531. doi:10.1101/2021.10.22.465531. S2CID239831170. {{cite journal}}: Cite journal requires |journal= (help)
van Der Heijden R, Jacobs DI, Snoeijer W, Hallard D, Verpoorte R (March 2004). "The Catharanthus alkaloids: pharmacognosy and biotechnology". Current Medicinal Chemistry. 11 (5): 607–28. doi:10.2174/0929867043455846. PMID15032608.
Ngo QA, Roussi F, Cormier A, Thoret S, Knossow M, Guénard D, Guéritte F (January 2009). "Synthesis and biological evaluation of vinca alkaloids and phomopsin hybrids". Journal of Medicinal Chemistry. 52 (1): 134–42. doi:10.1021/jm801064y. PMID19072542.
"Mebendazole". Drugs.com. The American Society of Health-System Pharmacists. Archived from the original on December 11, 2019. Retrieved August 18, 2015.
"Albendazole". Drugs.com. The American Society of Health-System Pharmacists. Archived from the original on September 23, 2015. Retrieved August 18, 2015.
Nogales E, Downing KH, Amos LA, Löwe J (June 1998). "Tubulin and FtsZ form a distinct family of GTPases". Nature Structural Biology. 5 (6): 451–8. doi:10.1038/nsb0698-451. PMID9628483. S2CID5945125.
Williams RC, Shah C, Sackett D (November 1999). "Separation of tubulin isoforms by isoelectric focusing in immobilized pH gradient gels". Analytical Biochemistry. 275 (2): 265–7. doi:10.1006/abio.1999.4326. PMID10552916.
Karki R, Mariani M, Andreoli M, He S, Scambia G, Shahabi S, Ferlini C (April 2013). "βIII-Tubulin: biomarker of taxane resistance or drug target?". Expert Opinion on Therapeutic Targets. 17 (4): 461–72. doi:10.1517/14728222.2013.766170. PMID23379899. S2CID26229777.
Malone, Lucia M.; Warring, Suzanne L.; Jackson, Simon A.; Warnecke, Carolin; Gardner, Paul P.; Gumy, Laura F.; Fineran, Peter C. (9 December 2019). "A jumbo phage that forms a nucleus-like structure evades CRISPR–Cas DNA targeting but is vulnerable to type III RNA-based immunity". Nature Microbiology. 5 (1): 48–55. bioRxiv10.1101/782524. doi:10.1038/s41564-019-0612-5. PMID31819217. S2CID209164667.
van Der Heijden R, Jacobs DI, Snoeijer W, Hallard D, Verpoorte R (March 2004). "The Catharanthus alkaloids: pharmacognosy and biotechnology". Current Medicinal Chemistry. 11 (5): 607–28. doi:10.2174/0929867043455846. PMID15032608.
Ngo QA, Roussi F, Cormier A, Thoret S, Knossow M, Guénard D, Guéritte F (January 2009). "Synthesis and biological evaluation of vinca alkaloids and phomopsin hybrids". Journal of Medicinal Chemistry. 52 (1): 134–42. doi:10.1021/jm801064y. PMID19072542.
Nogales E, Downing KH, Amos LA, Löwe J (June 1998). "Tubulin and FtsZ form a distinct family of GTPases". Nature Structural Biology. 5 (6): 451–8. doi:10.1038/nsb0698-451. PMID9628483. S2CID5945125.
Karki R, Mariani M, Andreoli M, He S, Scambia G, Shahabi S, Ferlini C (April 2013). "βIII-Tubulin: biomarker of taxane resistance or drug target?". Expert Opinion on Therapeutic Targets. 17 (4): 461–72. doi:10.1517/14728222.2013.766170. PMID23379899. S2CID26229777.
Malone, Lucia M.; Warring, Suzanne L.; Jackson, Simon A.; Warnecke, Carolin; Gardner, Paul P.; Gumy, Laura F.; Fineran, Peter C. (9 December 2019). "A jumbo phage that forms a nucleus-like structure evades CRISPR–Cas DNA targeting but is vulnerable to type III RNA-based immunity". Nature Microbiology. 5 (1): 48–55. bioRxiv10.1101/782524. doi:10.1038/s41564-019-0612-5. PMID31819217. S2CID209164667.
Akıl, Caner; Ali, Samson; Tran, Linh T.; Gaillard, Jeremie; Li, Wenfei; Hayashida, Kenichi; Hirose, Mika; Kato, Takayuki; Oshima, Atsunori; Fujishima, Kosuke; Blanchoin, Laurent; Narita, Akihiro; Robinson, Robert C. (2021). "Structure and dynamics of Odinarchaeota tubulin and the implications for eukaryotic microtubule evolution". bioRxiv10.1101/2021.10.22.465531. doi:10.1101/2021.10.22.465531. S2CID239831170. {{cite journal}}: Cite journal requires |journal= (help)
web.archive.org
"Mebendazole". Drugs.com. The American Society of Health-System Pharmacists. Archived from the original on December 11, 2019. Retrieved August 18, 2015.
"Albendazole". Drugs.com. The American Society of Health-System Pharmacists. Archived from the original on September 23, 2015. Retrieved August 18, 2015.